Impact News +++ HSBC Q1 Pre-tax Profit Drops, Lifts FY26 Banking NII View (AFX) +++ HSBC Aktie -3,35%

IMMUTEP Aktie

>IMMUTEP Aktienkurs

0.038 EUR (TradegateBSX)

Ask: 0.043 EUR / 10000 Stück

Bid: 0.032 EUR / 10000 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

IMMUTEP Aktie über LYNX handeln

Intraday

1 Jahr

>IMMUTEP Performance

1 Woche: +0,7%

1 Monat: +21,8%

3 Monate: -83,7%

6 Monate: -75,2%

1 Jahr: -75,7%

laufendes Jahr: -83,9%

>IMMUTEP Aktie

Name:

IMMUTEP LTD

Land:

Australien

Sektor:

Gesundheit

ISIN/ Wkn:

AU000000IMM6 / A2H81H

Symbol/ Ticker:

YP1B (Frankfurt)

Kürzel:

FRA:YP1B, ETR:YP1B, YP1B:GR

Index:

Webseite:

https://www.immutep.com/

Profil:

Immutep Limited is a late-stage biotechnology company specializing in the development of innovative immunotherapies for cancer and autoimmune diseases. Headquartered in Sydney, Australia, with operations spanning Europe and the United States, Immutep..
>Volltext..

Marktkapitalisierung:

55.22 Mio. EUR

Unternehmenswert:

-0.46 Mio. EUR

Umsatz:

2.32 Mio. EUR

EBITDA:

-49.09 Mio. EUR

Nettogewinn:

-47.77 Mio. EUR

Gewinn je Aktie:

-0.03 EUR

Schulden:

0.69 Mio. EUR

Liquide Mittel:

41.42 Mio. EUR

Operativer Cashflow:

-35.38 Mio. EUR

Bargeldquote:

2.11

Umsatzwachstum:

Gewinnwachstum:

-81.86%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

IMMUTEP

Letzte Datenerhebung:

05.05.26

>IMMUTEP Kennzahlen

Aktien/ Unternehmen:

Aktien: 1473.72 Mio. St.

Frei handelbar: 97.05%

Leerverk. Aktien: -

Rückkaufquote: -

Mitarbeiter: -

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Neutral

Kursziel: 869%

Bewertung:

KGV: -

KGV lG: -

KUV: 25.41

KBV: 1

PEG-Ratio: -0.02

EV/EBITDA: -

Rentabilität:

Bruttomarge: 45.35%

Gewinnmarge: -2056.63%

Operative Marge: -2168.05%

Managementeffizenz:

Gesamtkaprendite: -50.93%

Eigenkaprendite: -61.85%

>IMMUTEP Peer Group

Gesundheit, Antikörper- Behandlung, Lungenerkrankungen & -behandlung/ Asthma, Autoimmunerkrankungen, Onkologie/ Krebs- Behandlung

>IMMUTEP Chart & Kurs - Tradegate

>IMMUTEP News

01.05.26 - 02:18	Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP (PR Newswire)
	NEW YORK, April 30, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading......

25.04.26 - 09:09	Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP (PR Newswire)
	NEW YORK, April 25, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading......

22.04.26 - 14:03

Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting (GlobeNewswire EN)

SYDNEY, AUSTRALIA, April 22, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage immunotherapy company targeting cancer and autoimmune diseases, today announces an abstract has been selected for poster presentation at the upcoming 2026 American Society of Clinical Oncology's (ASCO) Annual Meeting, taking place in-person and online from 29 May-2 June 2026 in Chicago, Illinois (United States)....

20.04.26 - 08:09	Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP (PR Newswire)
	NEW YORK, April 20, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading......

17.04.26 - 08:30	ASX Runners of the Week: Bison, Genetic Signatures, Narryer & Immutep (SMH)
	The Bulls N' Bears ASX Runner of the Week is… Bison Resources, which exploded on debut, as punters piled into its prime Nevada gold-silver projects amid ongoing fuel security chaos....

15.04.26 - 14:03

Immutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma (GlobeNewswire EN)

SYDNEY, AUSTRALIA, April 15, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company targeting cancer and autoimmune diseases, today announces that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for eftilagimod alfa (“efti”) for the treatment of Soft Tissue Sarcoma (STS), a rare cancer with significant unmet medical need....

15.04.26 - 07:45	Australia′s Immutep rallies over 100% on FDA orphan drug designation (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

15.04.26 - 06:12	Why this ASX biotech stock just rocketed 89% today (Fool)
	Immutep shares rocket after a fresh FDA win The post Why this ASX biotech stock just rocketed 89% today appeared first on The Motley Fool Australia....

15.04.26 - 04:12	Immutep Granted FDA Orphan Drug Designation for Efti in Soft Tissue Sarcoma (Small Caps)
	Immutep wins FDA Orphan Drug Designation for eftilagimod alfa in soft tissue sarcoma, boosting exclusivity and regulatory support as TACTI-004 winds down....

14.04.26 - 20:27	Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP (PR Newswire)
	NEW YORK, April 14, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading......

10.04.26 - 00:03	Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP (PR Newswire)
	NEW YORK, April 9, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading......

04.04.26 - 18:09	Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP (PR Newswire)
	NEW YORK, April 4, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep Ltd. may have issued materially misleading......

02.04.26 - 16:07	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep Limited - IMMP (PR Newswire)
	NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation......

24.03.26 - 06:12	Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP (PR Newswire)
	NEW YORK, March 24, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially......

20.03.26 - 07:30	ASX Runners of the Week: Immutep, Blue Star Helium & Patagonia (SMH)
	The Bulls N' Bears ASX Runner of the Week is… Immutep. The oncology mid-cap bounced hard from last week's 90 per cent drop, gaining 53 per cent after a brutal sell-off....

20.03.26 - 02:30	HotList stocks: Northern Star, Immutep, Lodestar, and other trending companies in Week 12 (Market Herald)
	Good afternoon, and welcome to the HotCopper HotList column. Every week, ASX…...

19.03.26 - 04:30	Thursday’s HotCopper trends: Racura, EVR, Immutep, and other daily topics \| March 19 (Market Herald)
	Racura is well out in front on the Australian bourse topic-wise today…...

18.03.26 - 22:31	IMMP Investor Alert: Immutep Ltd. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky (PR Newswire)
	Immutep Reported TACTI-004 Futility Analysis Was "On Track" in January 2026 -- Weeks Later the Trial Was Halted After Failing to Meet Efficacy Endpoints NEW YORK, March 18, 2026 /PRNewswire/ -- Shareholders of Immutep Ltd. (NASDAQ: IMMP) who lost money are urged to act now. On January 30,......

18.03.26 - 20:03	Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP (PR Newswire)
	NEW YORK, March 18, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially......

13.03.26 - 13:18	Immutep-Aktie stürzt nach Abbruch von Lungenkrebsstudie um 80 % ab (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram